Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GeneDx Holdings (WGS) Tax Provisions (2022 - 2026)

GeneDx Holdings has reported Tax Provisions over the past 5 years, most recently at $897000.0 for Q1 2026.

  • Quarterly Tax Provisions rose 124.25% to $897000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $335000.0 through Mar 2026, up 141.01% year-over-year, with the annual reading at -$116000.0 for FY2025, 66.18% up from the prior year.
  • Tax Provisions was $897000.0 for Q1 2026 at GeneDx Holdings, up from -$516000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $897000.0 in Q1 2026 and troughed at -$49.1 million in Q2 2022.
  • The 5-year median for Tax Provisions is -$114500.0 (2023), against an average of -$3.1 million.
  • The largest YoY upside for Tax Provisions was 587.8% in 2025 against a maximum downside of 2050.0% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $48000.0 in 2022, then crashed by 987.5% to -$426000.0 in 2023, then soared by 94.37% to -$24000.0 in 2024, then tumbled by 2050.0% to -$516000.0 in 2025, then surged by 273.84% to $897000.0 in 2026.
  • Per Business Quant, the three most recent readings for WGS's Tax Provisions are $897000.0 (Q1 2026), -$516000.0 (Q4 2025), and $200000.0 (Q3 2025).